Thioredoxin-1 attenuates indomethacin-induced gastric mucosal injury in mice

References

• Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992; 327: 749–754
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Naito Y, Kishi A, Tomii T, Kaneko T, Iinuma S, Ichikawa H, Yasuda M, Takahashi S, Kondo M. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993; 34: 732–737
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay D, Biswas K, Bandyopadhyay U, Reiter RJ, Banerjee RK. Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical. J Pineal Res 2000; 29: 143–151
   PubMed Web of Science ®Google Scholar
• Molina V, Valdes S, Carbajal D, Arruzazabala L, Menendez R, Mas R. Antioxidant effect of D-002 on gastric mucosa of rats with experimentally induced injury. J Med Food 2001; 4: 79–83
   PubMedGoogle Scholar
• Deveraux QL, Reed JC. IAP family proteins–suppressors of apoptosis. Genes Dev 1999; 13: 239–252
   PubMed Web of Science ®Google Scholar
• Chiou SK, Moon WS, Jones MK, Tarnawski AS. Survivin expression in the stomach: Implications for mucosal integrity and protection. Biochem Biophys Res Commun 2003; 305: 374–379
   PubMed Web of Science ®Google Scholar
• Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski AS. Survivin: A novel target for indomethacin-induced gastric injury. Gastroenterology 2005; 128: 63–73
   PubMed Web of Science ®Google Scholar
• Holmgren A. Thioredoxin. Annu Rev Biochem 1985; 54: 237–271
   PubMed Web of Science ®Google Scholar
• Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264: 13963–13966
   PubMed Web of Science ®Google Scholar
• Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 1989; 8: 757–764
   PubMed Web of Science ®Google Scholar
• Kato A, Odamaki M, Nakamura H, Yodoi J, Hishida A. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection. Kidney Int 2003; 63: 2262–2268
   PubMed Web of Science ®Google Scholar
• Higashikubo A, Tanaka N, Noda N, Maeda I, Yagi K, Mizoguchi T, Nanri H. Increase in thioredoxin activity of intestinal epithelial cells mediated by oxidative stress. Biol Pharm Bull 1999; 22: 900–903
   PubMed Web of Science ®Google Scholar
• Kim YC, Yamaguchi Y, Kondo N, Masutani H, Yodoi J. Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 2003; 22: 1860–1865
   PubMed Web of Science ®Google Scholar
• Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem 1999; 274: 3182–3188
   PubMed Web of Science ®Google Scholar
• Das KC, Das CK. Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: Redox independent functions. Biochem Biophys Res Commun 2000; 277: 443–447
   PubMed Web of Science ®Google Scholar
• Mitsui A, Hirakawa T, Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 1992; 186: 1220–1226
   PubMed Web of Science ®Google Scholar
• Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998; 17: 2596–2606
   PubMed Web of Science ®Google Scholar
• Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 1999; 96: 4131–4136
   PubMed Web of Science ®Google Scholar
• Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, Inamoto T, Yamaoka Y, Ozawa K, Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 1994; 42: 75–80
   PubMed Web of Science ®Google Scholar
• Bai J, Nakamura H, Hattori I, Tanito M, Yodoi J. Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci Lett 2002; 321: 81–84
   PubMed Web of Science ®Google Scholar
• Hattori I, Takagi Y, Nakamura H, Nozaki K, Bai J, Kondo N, Sugino T, Nishimura M, Hashimoto N, Yodoi J. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal 2004; 6: 81–87
   PubMed Web of Science ®Google Scholar
• Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young HA, Aizawa H, Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med 2003; 168: 1075–1083
   PubMed Web of Science ®Google Scholar
• Dekigai H, Nakamura H, Bai J, Tanito M, Masutani H, Hirota K, Matsui H, Murakami M, Yodoi J. Geranylgeranylacetone promotes induction and secretion of thioredoxin in gastric mucosal cells and peripheral blood lymphocytes. Free Radic Res 2001; 35: 23–30
   PubMed Web of Science ®Google Scholar
• Hirota K, Nakamura H, Arai T, Ishii H, Bai J, Itoh T, Fukuda K, Yodoi J. Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes. Biochem Biophys Res Commun 2000; 275: 825–830
   PubMed Web of Science ®Google Scholar
• Tanito M, Masutani H, Nakamura H, Oka S, Ohira A, Yodoi J. Attenuation of retinal photooxidative damage in thioredoxin transgenic mice. Neurosci Lett 2002; 326: 142–146
   PubMed Web of Science ®Google Scholar
• Kasuno K, Nakamura H, Ono T, Muso E, Yodoi J. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int 2003; 64: 1273–1282
   PubMed Web of Science ®Google Scholar
• Takagi Y, Tokime T, Nozaki K, Gon Y, Kikuchi H, Yodoi J. Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: Immunohistochemical and hybridization studies of thioredoxin. J Cereb Blood Flow Metab 1998; 18: 206–214
   PubMed Web of Science ®Google Scholar
• Kondo N, Ishii Y, Kwon YW, Tanito M, Horita H, Nishinaka Y, Nakamura H, Yodoi J. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 2004; 172: 442–448
   PubMed Web of Science ®Google Scholar
• Kaimul Ahsan M, Nakamura H, Tanito M, Yamada K, Utsumi H, Yodoi J. Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEPinduced downregulation of Akt. Free Radic Biol Med 2005; 39: 1549–1559
   PubMed Web of Science ®Google Scholar
• Whittle BJ, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980; 284: 271–273
   PubMed Web of Science ®Google Scholar
• Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S, Hirakawa T, Inoue T, Yodoi J. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 2002; 4: 693–696
   PubMed Web of Science ®Google Scholar
• Okuyama H, Nakamura H, Shimahara Y, Araya S, Kawada N, Yamaoka Y, Yodoi J. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology 2003; 37: 1015–1025
   PubMed Web of Science ®Google Scholar
• Kawasaki K, Nishio A, Nakamura H, Uchida K, Fukui T, Ohana M, Yoshizawa H, Ohashi S, Tamaki H, Matsuura M, Asada M, Nishi T, Nakase H, Toyokuni S, Liu W, Yodoi J, Okazaki K, Chiba T. Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1. Lab Invest 2005; 85: 1104–1117
   Google Scholar
• Wallace JL. Prostaglandins, NSAIDs, and cytoprotection. Gastroenterol Clin North Am 1992; 21: 631–641
   PubMed Web of Science ®Google Scholar
• Nagano Y, Matsui H, Muramatsu M, Shimokawa O, Shibahara T, Yanaka A, Nakahara A, Matsuzaki Y, Tanaka N, Nakamura Y. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci 2005; 1(50 Suppl)S76–S83
   Google Scholar
• Whittle BJ, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607–611
   PubMed Web of Science ®Google Scholar
• Brzozowski T, Konturek SJ, Sliwowski Z, Drozdowicz D, Zaczek M, Kedra D. Role of l-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing. J Gastroenterol 1997; 32: 442–452
   PubMed Web of Science ®Google Scholar
• Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 2003; 278: 50226–50233
   PubMed Web of Science ®Google Scholar
• Pallares J, Martinez-Guitarte JL, Dolcet X, Llobet D, Rue M, Palacios J, Prat J, Matias-Guiu X. Survivin expression in endometrial carcinoma: A tissue microarray study with correlation with PTEN and STAT-3. Int J Gynecol Pathol 2005; 24: 247–253
   PubMed Web of Science ®Google Scholar
• Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96: 4240–4245
   PubMed Web of Science ®Google Scholar
• Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: A mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 2004; 429: 123–133
   PubMed Web of Science ®Google Scholar